Medtronic plc. (MDT) Stake Boosted by First National Trust Co.

First National Trust Co. lifted its position in shares of Medtronic plc. (NYSE:MDT) by 17.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,774 shares of the medical technology company’s stock after purchasing an additional 5,270 shares during the quarter. First National Trust Co.’s holdings in Medtronic were worth $2,705,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Hudock Capital Group LLC boosted its position in shares of Medtronic by 0.5% during the second quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock worth $194,000 after purchasing an additional 11 shares in the last quarter. Triangle Securities Wealth Management raised its holdings in shares of Medtronic by 0.3% during the second quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock worth $390,000 after acquiring an additional 15 shares during the period. IFC Holdings Incorporated FL raised its holdings in shares of Medtronic by 0.3% during the second quarter. IFC Holdings Incorporated FL now owns 5,673 shares of the medical technology company’s stock worth $501,000 after acquiring an additional 17 shares during the period. Arcus Capital Partners LLC raised its holdings in shares of Medtronic by 0.8% during the second quarter. Arcus Capital Partners LLC now owns 3,249 shares of the medical technology company’s stock worth $288,000 after acquiring an additional 25 shares during the period. Finally, Guardian Life Insurance Co. of America raised its holdings in shares of Medtronic by 0.6% during the first quarter. Guardian Life Insurance Co. of America now owns 5,288 shares of the medical technology company’s stock worth $426,000 after acquiring an additional 29 shares during the period. 81.74% of the stock is currently owned by institutional investors.

MDT has been the topic of a number of research analyst reports. Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Medtronic in a report on Thursday, November 9th. BidaskClub lowered shares of Medtronic from a “hold” rating to a “sell” rating in a report on Saturday, August 26th. Zacks Investment Research lowered shares of Medtronic from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. SunTrust Banks set a $92.00 price objective on shares of Medtronic and gave the stock a “buy” rating in a report on Sunday, November 19th. Finally, Royal Bank of Canada dropped their price objective on shares of Medtronic from $90.00 to $85.00 and set an “outperform” rating on the stock in a report on Monday, October 9th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Medtronic currently has a consensus rating of “Hold” and an average price target of $88.57.

In other news, EVP Bryan C. Hanson sold 16,000 shares of the business’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $79.02, for a total transaction of $1,264,320.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders have sold a total of 48,000 shares of company stock worth $3,837,920 over the last 90 days. 0.31% of the stock is owned by company insiders.

Medtronic plc. (MDT) opened at $81.38 on Thursday. The firm has a market cap of $111,040.97, a PE ratio of 17.68, a PEG ratio of 2.26 and a beta of 1.00. Medtronic plc. has a 52 week low of $69.35 and a 52 week high of $89.72. The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.05 and a current ratio of 2.40.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, November 21st. The medical technology company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $0.99 by $0.08. The company had revenue of $7.05 billion for the quarter, compared to analyst estimates of $7.05 billion. Medtronic had a net margin of 16.93% and a return on equity of 12.63%. Medtronic’s revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.12 EPS. research analysts predict that Medtronic plc. will post 4.77 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 19th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.46 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.84 annualized dividend and a dividend yield of 2.26%. Medtronic’s dividend payout ratio is presently 50.41%.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://sportsperspectives.com/2017/12/21/medtronic-plc-mdt-stake-boosted-by-first-national-trust-co.html.

Medtronic Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply